Authors:
Markman, M
Spriggs, D
Burger, RA
Carson, LF
Lentz, SS
Gallion, H
Citation: M. Markman et al., Phase I trial of ifosfamide and 24-h infusional paclitaxel in pelvic malignancies: A Gynecologic Oncology Group study, GYNECOL ONC, 80(3), 2001, pp. 359-363
Authors:
Montana, GS
Thomas, GM
Moore, DH
Saxer, A
Mangan, CE
Lentz, SS
Averette, HE
Citation: Gs. Montana et al., Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: A Gynecologic Oncology Group study, INT J RAD O, 48(4), 2000, pp. 1007-1013
Authors:
Sutton, G
Brunetto, VL
Kilgore, L
Soper, JT
McGehee, R
Olt, G
Lentz, SS
Sorosky, J
Hsiu, JG
Citation: G. Sutton et al., A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A gynecologic oncology group study, GYNECOL ONC, 79(2), 2000, pp. 147-153
Authors:
Berek, JS
Markman, M
Stonebraker, B
Lentz, SS
Adelson, MD
DeGeest, K
Moore, D
Citation: Js. Berek et al., Intraperitoneal interferon-alpha in residual ovarian carcinoma: A Phase IIGynecologic Oncology Group study, GYNECOL ONC, 75(1), 1999, pp. 10-14
Authors:
Sedlis, A
Bundy, BN
Rotman, MZ
Lentz, SS
Muderspach, LI
Zaino, RJ
Citation: A. Sedlis et al., A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage is carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A gynecologic oncology group study, GYNECOL ONC, 73(2), 1999, pp. 177-183